UniQuest is the commercialisation company of The University of Queensland (UQ).  In partnership with UQ researchers, we create impact through the commercialisation of UQ intellectual property (IP). 

Established in 1984, UniQuest’s commercialisation track record positions UQ as the leader of research commercialisation in Australasia.  UniQuest has formed more than 100 start-up companies built on UQ IP.  UniQuest’s track record and notable successes include the blockbuster cervical cancer vaccine Gardasil® and start-up companies Spinifex Pharmaceuticals Inc and Inflazome Ltd, which were acquired in two of the largest university start-up exits in Australian history. 

Biotechnology

Business Development

Life Sciences

Venture Capital

UniQuest

Dr Dean Moss

Rob Hewitt

Jane Malloch

This department focuses on the commercialization of scientific innovations in the life sciences and physical sciences sectors.

Commercialisation Department

This department focuses on researching and developing new pharmaceutical compounds and therapies.

Drug Discovery

This department provides strategic oversight and governance to guide the organization's direction and performance.

Executive Leadership

This department focuses on creating and managing messaging and media strategies to enhance brand visibility and engage audiences.

Marketing Communications

This department manages contracts and optimizes commercial processes.

Commercial Operations

This department focuses on overseeing and managing investment portfolios to maximize returns and align with strategic objectives.

UniQuest

Org chart

Teams

Commercialisation Department

Drug Discovery

Executive Leadership

Marketing Communications

Commercial Operations

Investment Management

Offices

UniQuest

Org chart

Teams

Commercialisation Department

Drug Discovery

Executive Leadership

Marketing Communications

Commercial Operations

Investment Management

Offices

Related companies